RMD vs SYK · P/E 29, rev $5.65B vs P/E 35, rev $6.59B
ResMed Inc (RMD) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the RMD and SYK stock pages for the full models.
Not investment advice.